Comparing Efficacy Between Two Protocols of Intravenous Insulin Infusion for Diabetic Adults in ICU

Launched by SUEZ CANAL UNIVERSITY · Jan 31, 2025

Keywords

ClinConnect Summary

This clinical trial is studying the best way to manage blood sugar levels in critically ill adult patients with diabetes who are in the intensive care unit (ICU). The researchers want to find out if a specific method of giving insulin through an intravenous (IV) drip, called the SCU protocol, is more effective than the method used by the NHS in the UK. By comparing these two approaches, they hope to improve blood sugar control for patients who are very sick and may be at risk for complications.

To participate in this trial, patients must be adults admitted to the ICU with a serious health issue and have an HbA1C level greater than 6.0, which indicates their diabetes is not well controlled. However, those who are pregnant, breastfeeding, or experiencing certain severe conditions like diabetic ketoacidosis will not be eligible. Participants will receive one of the two insulin protocols and will be monitored to see how well their blood sugar levels are managed. This trial is currently recruiting patients, and it is an important step towards better care for diabetics in critical situations.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patients who admitted to the hospital with a potentially life-threatening condition (Critically ill patients) with HbA1C \>6.0.
• Exclusion Criteria:
• • DKA patients.
• • Pregnant or breast-feeding patients.
• • Hyperosmolar Non-Ketotic Coma.